BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brugnatelli V, Turco F, Freo U, Zanette G. Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment. Front Neurosci 2020;14:371. [PMID: 32372912 DOI: 10.3389/fnins.2020.00371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gigante I, Tutino V, Russo F, De Nunzio V, Coletta S, Armentano R, Crovace A, Caruso MG, Orlando A, Notarnicola M. Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet. Int J Mol Sci 2021;22:2880. [PMID: 33809047 DOI: 10.3390/ijms22062880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Singla RK, Guimarães AG, Zengin G. Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation. Front Pharmacol 2020;11:623399. [PMID: 33519489 DOI: 10.3389/fphar.2020.623399] [Reference Citation Analysis]
3 van Orten-Luiten AB, de Roos NM, Majait S, Witteman BJM, Witkamp RF. Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing. Cannabis Cannabinoid Res 2021. [PMID: 33998882 DOI: 10.1089/can.2020.0087] [Reference Citation Analysis]
4 Liu JJ, Brenner DM. Review article: current and future treatment approaches for IBS with constipation. Aliment Pharmacol Ther 2021;54 Suppl 1:S53-62. [PMID: 34927760 DOI: 10.1111/apt.16607] [Reference Citation Analysis]